Nuvelo News
Most Popular Nuvelo Story
Bayer plans to beef up biotech pipeline
Bayer Healthcare says it will aggressively expand its biotech pipeline in the year ahead, concentrating on new development pacts in cardiology, hematology and oncology. The company is looking to strike new deals similar to the ones it has reached with Nuvelo and Onyx Pharmaceuticals. Hans Bishop, the former senior v.p. for Chiron's UK operations, will likely head up many of these new ventures. Bishop is expected to be tapped as the next president of the company's hematology and cardiology …
... Read more...Latest Headlines
- September 25, 2008
- August 2, 2007
- January 8, 2007
- January 1, 2007
- December 10, 2006
- December 10, 2006
- August 2, 2006
- July 31, 2006
- March 28, 2006
- February 26, 2006
- January 22, 2006
- January 4, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
